- Home
- APWC vs CGTX Comparison
APWC vs CGTX Comparison
Compare APWC & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APWC
- CGTX
- Stock Information
- Founded
- APWC 1996
- CGTX 2007
- Country
- APWC Taiwan
- CGTX United States
- Employees
- APWC N/A
- CGTX N/A
- Industry
- APWC Telecommunications Equipment
- CGTX Biotechnology: Pharmaceutical Preparations
- Sector
- APWC Industrials
- CGTX Health Care
- Exchange
- APWC Nasdaq
- CGTX Nasdaq
- Market Cap
- APWC 35.3M
- CGTX 30.0M
- IPO Year
- APWC 1997
- CGTX 2021
- Fundamental
- Price
- APWC $1.57
- CGTX $0.58
- Analyst Decision
- APWC
- CGTX Strong Buy
- Analyst Count
- APWC 0
- CGTX 6
- Target Price
- APWC N/A
- CGTX $8.30
- AVG Volume (30 Days)
- APWC 7.1K
- CGTX 809.4K
- Earning Date
- APWC 08-26-2024
- CGTX 03-25-2025
- Dividend Yield
- APWC N/A
- CGTX N/A
- EPS Growth
- APWC N/A
- CGTX N/A
- EPS
- APWC 0.18
- CGTX N/A
- Revenue
- APWC $468,125,000.00
- CGTX N/A
- Revenue This Year
- APWC N/A
- CGTX N/A
- Revenue Next Year
- APWC N/A
- CGTX N/A
- P/E Ratio
- APWC $8.84
- CGTX N/A
- Revenue Growth
- APWC 12.16
- CGTX N/A
- 52 Week Low
- APWC $1.20
- CGTX $0.34
- 52 Week High
- APWC $2.02
- CGTX $2.95
- Technical
- Relative Strength Index (RSI)
- APWC 48.26
- CGTX 40.43
- Support Level
- APWC $1.59
- CGTX $0.57
- Resistance Level
- APWC $1.81
- CGTX $0.65
- Average True Range (ATR)
- APWC 0.11
- CGTX 0.05
- MACD
- APWC -0.00
- CGTX -0.01
- Stochastic Oscillator
- APWC 23.17
- CGTX 9.46
About APWC Asia Pacific Wire & Cable Corporation Ltd. (Bermuda)
Asia Pacific Wire & Cable Corp Ltd is a holding company. It is principally engaged in owning operating companies engaged in the power cable, telecommunication cable, enameled wire, and electronic cable industry. It also provides project engineering services to customers. Some of the company's products are Bare wires, Power cables, Communication cables, Electronic wires & cables, and Enamelled wires. The company's geographical segments are North Asia, Thailand, and Rest of the World.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.